Diphtheria Antibodies and T lymphocyte Counts in Patients Infected with HIV-1

AUTOR(ES)

Speranza, Francisco A. B., Ishii, Solange K., Thuler, Luiz C. S., Damasco, Paulo V., Hirata Jr, Raphael, Mattos-Guaraldi, Ana L., Milagres, Lucimar G.

FONTE

Braz. J. Microbiol.

DATA DE PUBLICAÇÃO

2012-09

RESUMO

We assessed the IgG levels anti-diphtheria (D-Ab) and T cell counts (CD4+ and CD8+) in HIV-1 infected subjects undergoing or not highly active antiretroviral therapy (HAART). Approximately 70% of all HIV-1 patients were unprotected against diphtheria. There were no differences in D-Ab according to CD4 counts. Untreated patients had higher D-Ab (geometric mean of 0.62 IU/ml) than HAART-patients (geometric mean of 0.39 IU/ml). The data indicated the necessity of keeping all HIV-1 patients up-to-date with their vaccination.

Documentos Relacionados

• CD8+ T lymphocyte responses target functionally important regions of Protease and Integrase in HIV-1 infected subjects
• Identificação de epitopos da protease de HIV-1 alvos de respostas de células T CD4+ em pacientes infectados pelo HIV-1
• Cytomegalovirus infection in gastrointestinal tracts of patients infected with HIV-1 or AIDS.
• Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis
• Anti-Human Immunodeficiency Virus Type 1 (HIV-1) CD8+ T-Lymphocyte Reactivity during Combination Antiretroviral Therapy in HIV-1-Infected Patients with Advanced Immunodeficiency